Novel Approaches to the Systemic Management of Uveal Melanoma

被引:0
作者
Shaheer Khan
Richard D. Carvajal
机构
[1] Columbia University Irving Medical Center,Department of Hematology and Oncology
[2] Herbert Irving Comprehensive Cancer Center,undefined
来源
Current Oncology Reports | 2020年 / 22卷
关键词
Uveal melanoma; Targeted therapy; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 108 条
[1]  
Aronow ME(2018)Uveal melanoma: 5-year update on Incidence, treatment, and survival (SEER 1973–2013) Ocul Oncol Pathol 4 145-151
[2]  
Topham AK(2011)Uveal melanoma: trends in incidence, treatment, and survival Ophthalmology 118 1881-1885
[3]  
Singh AD(2007)Incidence of uveal melanoma in Europe Ophthalmology 114 2309-2315
[4]  
Singh AD(2005)Incidence of noncutaneous melanomas in the U.S. Cancer 103 1000-1007
[5]  
Turell ME(2015)Epidemiological trends in uveal melanoma Br J Ophthalmol 99 1550-1553
[6]  
Topham AK(2012)Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients Ophthalmology 119 1582-1589
[7]  
Virgili G(2005)Estimating the risk of malignant transformation of a choroidal nevus Ophthalmology 112 1784-1789
[8]  
McLaughlin CC(2013)Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes JAMA Ophthalmol 131 993-1003
[9]  
Andreoli MT(2009)The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis Ophthalmology 116 536-543.e2
[10]  
Mieler WF(2016)Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases Clin Genet 89 285-294